Literature DB >> 27069164

Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer.

Mignon-Denise Keyver-Paik1, Janne Myriam Arden2, Christine Lüders3, Thore Thiesler3, Alina Abramian4, Tobias Hoeller5, Thomas Hecking4, Tiyasha Hosne Ayub4, Anna Doeser4, Christina Kaiser4, Walther Kuhn4.   

Abstract

BACKGROUND: Complete cytoreduction is the most important prognostic factor in ovarian cancer. However, there exist conflicting data on whether the removal of microscopic tumor metastasis in macroscopically unsuspicious retroperitoneal lymph nodes is beneficial. PATIENTS AND METHODS: Ovarian cancer tissues and tissues from lymph node metastasis of 30 patients with FIGO IIIC or IV disease undergoing neoadjuvant chemotherapy (NACT) were obtained and assessed using a validated regression score. Histopathological markers, size of largest tumor focus, and overall score were evaluated in lymph node and ovarian tissue. Regression and known prognostic factors were analyzed for influence on survival.
RESULTS: No difference in the overall score between lymph nodes and ovarian tissue was shown, however, single parameters such as fibrosis and pattern of tumor infiltration, were significantly different.
CONCLUSION: The pattern of tumor regression in lymph nodes and ovarian tissue are of prognostic value. Lymph node dissection even of unsuspicious nodes should, therefore, be performed. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Ovarian cancer; lymph nodes; neoadjuvant chemotherapy; tumor regression

Mesh:

Substances:

Year:  2016        PMID: 27069164

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report.

Authors:  Guo Tian; Tian'an Jiang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 2.  Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase.

Authors:  Laurie G Hudson; Jennifer M Gillette; Huining Kang; Melanie R Rivera; Angela Wandinger-Ness
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.